Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Guandalini

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry|February 28, 2017
Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituentsMaria Vittoria Martino, Luca Guandalini, Lorenzo Di Cesare Mannelli, et al.
Bioorganic & Medicinal Chemistry|May 6, 2008
Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivativesSilvia Dei, Cristina Bellucci, Michela Buccioni, et al.
Journal of Medicinal Chemistry|March 9, 2011
Synthesis and biological evaluation of 3,7-diazabicyclo[4.3.0]nonan-8-ones as potential nootropic and analgesic drugsElisabetta Martini, Lorenzo Di Cesare Mannelli, Gianluca Bartolucci, et al.
Bioorganic & Medicinal Chemistry|September 30, 2009
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancersElisabetta Martini, Alberto Salvicchi, Carla Ghelardini, et al.
European Journal of Medicinal Chemistry|October 6, 2014
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl estersSilvia Dei, Marcella Coronnello, Elisa Floriddia, et al.
Journal of Medicinal Chemistry|August 28, 2010
Design, synthesis, and preliminary biological evaluation of new isoform-selective f-current blockersMichele Melchiorre, Martina Del Lungo, Luca Guandalini, et al.
Journal of Medicinal Chemistry|January 22, 2005
Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modelingBente Frølund, Lars S Jensen, Luca Guandalini, et al.
Biochemical Pharmacology|March 22, 2016
Carbachol dimers as homobivalent modulators of muscarinic receptorsRosanna Matucci, Marta Nesi, Maria Vittoria Martino, et al.
Journal of Medicinal Chemistry|February 20, 2007
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structureSilvia Dei, Cristina Bellucci, Michela Buccioni, et al.
Journal of Medicinal Chemistry|June 12, 2008
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonistsSerena Scapecchi, Marta Nesi, Rosanna Matucci, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|February 28, 2017
Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituentsMaria Vittoria Martino, Luca Guandalini, Lorenzo Di Cesare Mannelli, et al.
Bioorganic & Medicinal Chemistry|May 6, 2008
Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivativesSilvia Dei, Cristina Bellucci, Michela Buccioni, et al.
Journal of Medicinal Chemistry|March 9, 2011
Synthesis and biological evaluation of 3,7-diazabicyclo[4.3.0]nonan-8-ones as potential nootropic and analgesic drugsElisabetta Martini, Lorenzo Di Cesare Mannelli, Gianluca Bartolucci, et al.
Bioorganic & Medicinal Chemistry|September 30, 2009
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancersElisabetta Martini, Alberto Salvicchi, Carla Ghelardini, et al.
European Journal of Medicinal Chemistry|October 6, 2014
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl estersSilvia Dei, Marcella Coronnello, Elisa Floriddia, et al.
Journal of Medicinal Chemistry|August 28, 2010
Design, synthesis, and preliminary biological evaluation of new isoform-selective f-current blockersMichele Melchiorre, Martina Del Lungo, Luca Guandalini, et al.
Journal of Medicinal Chemistry|January 22, 2005
Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modelingBente Frølund, Lars S Jensen, Luca Guandalini, et al.
Biochemical Pharmacology|March 22, 2016
Carbachol dimers as homobivalent modulators of muscarinic receptorsRosanna Matucci, Marta Nesi, Maria Vittoria Martino, et al.
Journal of Medicinal Chemistry|February 20, 2007
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structureSilvia Dei, Cristina Bellucci, Michela Buccioni, et al.
Journal of Medicinal Chemistry|June 12, 2008
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonistsSerena Scapecchi, Marta Nesi, Rosanna Matucci, et al.
Pageof 4